Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
1.20
20.36
1,696.67%
Share Warrants & Outstandings
Total Reserve
-167.80
52.37
-220.17
-420.41%
Shareholder's Funds
-146.24
53.57
-199.81
-372.99%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
3.04
158.21
5,204.28%
Secured Loans
0.00
0.62
-0.62
-100.00%
Unsecured Loans
161.25
2.42
158.83
6,563.22%
Deferred Tax Assets / Liabilities
0.00
1.43
-1.43
-100.00%
Other Long Term Liabilities
45.00
0.74
44.26
5,981.08%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.38
2.68
705.26%
Total Non-Current Liabilities
211.75
5.59
206.16
3,688.01%
Current Liabilities
Trade Payables
18.15
9.83
8.32
84.64%
Other Current Liabilities
33.63
4.16
29.47
708.41%
Short Term Borrowings
50.96
1.05
49.91
4,753.33%
Short Term Provisions
0.79
0.03
0.76
2,533.33%
Total Current Liabilities
103.53
15.08
88.45
586.54%
Total Liabilities
169.04
74.24
94.80
127.69%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
46.41
267.70
576.82%
Less: Accumulated Depreciation
168.40
23.06
145.34
630.27%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
23.35
122.35
523.98%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
9.32
-8.08
-86.70%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.01
-0.01
-100.00%
Long Term Loans & Advances
9.98
0.00
9.98
0.00%
Other Non Current Assets
0.00
0.19
-0.19
-100.00%
Total Non-Current Assets
158.78
34.16
124.62
364.81%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
7.21
-1.18
-16.37%
Sundry Debtors
0.05
25.74
-25.69
-99.81%
Cash and Bank
0.14
2.19
-2.05
-93.61%
Other Current Assets
0.47
0.12
0.35
291.67%
Short Term Loans and Advances
3.56
4.82
-1.26
-26.14%
Total Current Assets
10.26
40.08
-29.82
-74.40%
Net Current Assets (Including Current Investments)
-93.27
25.00
-118.27
-473.08%
Total Current Assets Excluding Current Investments
10.26
40.08
-29.82
-74.40%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
74.24
94.80
127.69%
Contingent Liabilities
8.47
3.26
5.21
159.82%
Total Debt
212.21
4.09
208.12
5,088.51%
Book Value per share (adjusted)
-67.83
446.41
-514.24
-115.19%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






